A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role

被引:5
|
作者
Grazzi, Licia [1 ]
Montisano, Danilo Antonio [1 ]
Rizzoli, Paul [2 ]
Guastafierro, Erika [3 ]
Marcassoli, Alessia [3 ]
Fornari, Arianna [3 ]
Raggi, Alberto [3 ]
机构
[1] Fdn IRRCS Ist Neurol Carlo Besta, Ctr Cefalee, I-20133 Milan, Italy
[2] Harvard Med Sch, Brigham & Womens Faulkner Hosp, John Graham Headacche Ctr, Boston, MA 02115 USA
[3] Fdn IRRCS Ist Neurol Carlo Besta, UOC Neurol Salute Pubbl & Disabil, I-20133 Milan, Italy
关键词
OnabotulinumtoxinA; chronic migraine; medication overuse headache; pain catastrophizing; cutaneous allodynia; PREEMPT; DAY-HOSPITAL WITHDRAWAL; CUTANEOUS ALLODYNIA; DISABILITY; VALIDATION; MANAGEMENT;
D O I
10.3390/toxins15020086
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Pain catastrophizing and cutaneous allodynia are commonly altered in patients with chronic migraine associated with medication overuse headache (CM-MOH) and tend to improve in parallel with clinical improvement. The relation between pain catastrophizing and cutaneous allodynia is poorly understood in patients with CM-MOH receiving OnabotulinumtoxinA therapy. In this single-arm open-label longitudinal observational study, patients with CM-MOH were assigned to structured withdrawal and then administered OnabotulinumtoxinA (5 sessions on a three-month basis, 195 UI per 31 sites). Headache frequency, medication intake, disability, impact, cutaneous allodynia and pain catastrophizing were evaluated with specific questionnaires. In total, 96 patients were enrolled and 79 completed the 12-month follow-up. With the exclusion of cutaneous allodynia and the magnification subscale of the pain catastrophizing questionnaire, all variables showed significant improvement by the sixth month, which was maintained at 12 months. Reduction of pain catastrophizing, and particularly of its helplessness subscale, was a significant predictor of reduction in headache frequency and medication intake. Pain catastrophizing is often implicated in the clinical improvement in patients with CM-MOH receiving behavioral treatments, but, in this study, also showed a role in patients receiving OnabotulinumtoxinA; combining OnabotulinumtoxinA and behavioral treatments specifically addressing pain catastrophizing might further enhance patients' clinical outcome.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Chronic Pain, Use of Mixed Analgesics/Opioids and Medication Overuse Are Associated with Chronic Daily Headache: Results of German Headache Study
    Yoon, Min-Suk
    Obermann, Mark
    Dommes, Peter
    Santowski, Iris
    Oezyurt, Melek
    Diener, Hans-Christopher
    Katsarava, Zaza
    NEUROLOGY, 2011, 76 (09) : A35 - A36
  • [32] Chronic pain, use of mixed analgesics/opioids and medication overuse are associated with chronic daily headache: results of german headache study
    Yoon, M. -S.
    Obermann, M.
    Dommes, P.
    Santowski, I.
    Oezyurt, M.
    Diener, H. C.
    Katsarava, Z.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S63 - S63
  • [33] Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache
    Lucchesi, Cinzia
    Baldacci, Filippo
    Cafalli, Martina
    Chico, Lucia
    Lo Gerfo, Annalisa
    Bonuccelli, Ubaldo
    Siciliano, Gabriele
    Gori, Sara
    HEADACHE, 2015, 55 (07): : 984 - 991
  • [34] Multidisciplinary approach to patients with chronic migraine and medication overuse: experience at the Besta Headache Center
    Grazzi, L.
    NEUROLOGICAL SCIENCES, 2013, 34 (01) : S19 - S21
  • [35] The Long-Term Efficacy and Safety of OnabotulinumtoxinA for the Prevention of Chronic Migraine in Patients with Medication Overuse: Results of the COMPEL Study
    Tepper, S. J.
    Wilson, M.
    Orejudos, A.
    Adams, Manack A.
    Blumenfeld, A.
    HEADACHE, 2018, 58 : 93 - 94
  • [36] Flunarizine is more effective than topiramate in patients with chronic migraine and medication overuse headache
    Gracia-Naya, M.
    Hernando-Quintana, N.
    Garcia-Gomara, M. J.
    Sanchez-Valiente, S.
    Rios, C.
    Santos-Lasaosa, S.
    Mauri, J. A.
    Artal-Roy, J.
    Latorre-Jimenez, A. M.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [37] Multidisciplinary approach to patients with chronic migraine and medication overuse: experience at the Besta Headache Center
    L. Grazzi
    Neurological Sciences, 2013, 34 : 19 - 21
  • [38] Endocannabinoids and serotonin levels in platelets of medication-overuse headache and chronic migraine patients
    Calabresi, P.
    Pini, L. A.
    Rossi, Cristiana
    Sarchielli, P.
    CEPHALALGIA, 2007, 27 (06) : 607 - 608
  • [39] Flunarizine is more effective than topiramate in patients with chronic migraine and medication overuse headache
    M Gracia-Naya
    N Hernando-Quintana
    MJ García-Gomara
    S Sánchez-Valiente
    C Ríos
    S Santos-Lasaosa
    JA Mauri
    J Artal-Roy
    AM Latorre-Jimenez
    The Journal of Headache and Pain, 2013, 14
  • [40] Medication overuse in Moldova Chronic migraine with and without medication overuse: the role of drug phobia and associated factors (according to the data of Headache Centre, Chisinau, the Republic of Moldova*)
    Moldovanu, Ion
    Odobescu, Stela
    Craciun, Cristina
    CEPHALALGIA, 2008, 28 (11) : 1229 - 1233